Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis

BACKGROUND: The need for more robust outcomes in multiple sclerosis (MS) clinical trials has been a main priority of the field for decades. Dissatisfaction with existing measures has led to several consensus meetings and initiatives over the past few decades in hopes of defining and gaining acceptan...

Descripción completa

Detalles Bibliográficos
Autores principales: Strober, Lauren, DeLuca, John, Benedict, Ralph HB, Jacobs, Adam, Cohen, Jeffrey A, Chiaravalloti, Nancy, Hudson, Lynn D, Rudick, Richard A, LaRocca, Nicholas G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826875/
https://www.ncbi.nlm.nih.gov/pubmed/30334474
http://dx.doi.org/10.1177/1352458518808204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826875/
https://www.ncbi.nlm.nih.gov/pubmed/30334474
http://dx.doi.org/10.1177/1352458518808204

Ejemplares similares